Chiba, Japan

Sakino To-E


Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:

goldMedal1 out of 832,680 
Other
 patents

Years Active: 2003

Loading Chart...
1 patent (USPTO):

Title: Sakino To-E: Innovator in Salicylamide Derivatives

Introduction

Sakino To-E is a notable inventor based in Chiba, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his work on salicylamide derivatives. His innovative approach has led to advancements in anti-inflammatory and immunosuppressive agents.

Latest Patents

Sakino To-E holds 1 patent related to salicylamide derivatives. This patent encompasses the production of salicylamide derivatives represented by specific formulae, along with the intermediates involved in their production. The derivatives are recognized for their effectiveness in inhibiting the activation of NF-κB, while exhibiting minimal side effects. This makes them valuable in the development of drugs aimed at treating various inflammatory conditions.

Career Highlights

Throughout his career, Sakino To-E has demonstrated a commitment to innovation in the pharmaceutical industry. His research has focused on creating compounds that can provide therapeutic benefits with reduced adverse effects. This dedication to improving drug efficacy and safety has positioned him as a respected figure in his field.

Collaborations

Sakino To-E has worked alongside esteemed colleagues such as Tomio Takeuchi and Kazuo Umezawa. Their collaborative efforts have contributed to the advancement of research in salicylamide derivatives and their applications in medicine.

Conclusion

Sakino To-E's work in the development of salicylamide derivatives highlights his role as an influential inventor in the pharmaceutical industry. His contributions continue to impact the field, paving the way for new therapeutic options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…